NCT06460779 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Colver A, McConachie H, Le Couteur A, Dovey-Pearce G, Mann KD, McDonagh JE, Pearce MS, Vale L, Merrick H, Parr JR; Transition Collaborative Group
A longitudinal, observational study of the features of transitional healthcare associated with better outcomes for young people with long-term conditions. BMC Med. 2018 Jul 23;16(1):111. doi: 10.1186/s12916-018-1102-y.
Liao YT, Hwang AW, Liao HF, Granlund M, Kang LJ
Understanding the Participation in Home, School, and Community Activities Reported by Children with Disabilities and Their Parents: A Pilot Study. Int J Environ Res Public Health. 2019 Jun 24;16(12):2217. doi: 10.3390/ijerph16122217.

Association of Age, Gross Motor Function With Activities of Daily Living, Participation in Home and Community in Children With Cerebral Palsy

Clinical trial NCT06460779 - References